Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 4Pancreatic Neoplasms 2Malnutrition 2Rectal Neoplasms 1Psychological Well-Being 1Pancreatitis, Chronic 1Ovarian Neoplasms 1Motor Activity 1Liver Neoplasms 1Glucose Metabolism Disorders 1Duodenal Neoplasms 1Diabetes, Gestational 1Colonic Neoplasms 1Cholangiocarcinoma 1Breast Neoplasms 1Bile Duct Neoplasms 1Ascites 1Appendiceal Neoplasms 1

Interventions

Gemcitabine 13Oxaliplatin 9Capecitabine 6lenvatinib 5apatinib 5Cisplatin 5tislelizumab 4Surgical Procedures, Operative 4Radiofrequency Ablation 4Neoadjuvant Therapy 4Fluorouracil 4toripalimab 3sintilimab 3Radiotherapy 3Leucovorin 3Irinotecan 3regorafenib 2pembrolizumab 2durvalumab 2camrelizumab 2Stents 2Photochemotherapy 2Immunotherapy 2Hepatectomy 2Folfox protocol 2Everolimus 2Drug Therapy 2Cholangiopancreatography, Endoscopic Retrograde 2Blood Specimen Collection 21-phenyl-3,3-dimethyltriazene 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Cholangiocarcinoma × Nutritional Status × Clear all
NCT01642875 2016-11-23

Early Oral Versus Enteral Nutrition After Pancreatoduodenectomy

Medical University of Warsaw

Phase 4 Unknown
96 enrolled
Gastrointestinal

Duodenal Neoplasms, Pancreatic Neoplasms, Cholangiocarcinoma, Pancreatitis, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡